Introduction
Running an independent infectious disease practice means juggling revenue streams that most general RCM vendors have never priced out: outpatient parenteral antimicrobial therapy (OPAT), infusion administration, hospital follow-up visits, prolonged antimicrobial courses, and buy-and-bill drug billing.
Each one carries its own authorization rules, documentation requirements, and denial triggers.
General healthcare RCM companies can handle claims submission, coding, eligibility checks, payment posting, and A/R follow-up. But doing those things well for a family medicine practice doesn't guarantee fluency in drug-unit reporting, infusion start/stop documentation, or site-of-care authorization disputes.
This guide compares five RCM companies (Optum, R1 RCM, NextGen Healthcare, athenahealth, and Greenway Health) against the specialty-specific demands of infectious disease billing in 2026. We look at service models, technology integration, payer and denial capabilities, and realistic fit for independent practices versus large health systems.
One note before you dig in: vendor pricing, certifications, and performance claims change often. Verify everything here against current primary sources before signing a contract.
Key Takeaways
- RCM partners include software vendors, outsourced billing firms, and hybrids spanning patient access to final payment
- Prioritize OPAT, infusion, buy-and-bill, and authorization capabilities over company size alone
- Match the partner to practice size, staffing, systems, and how much control you want to keep
- Vet integration, denial ownership, reporting, security, and contract terms before you sign
Overview of Healthcare RCM for Infectious Disease Practices
The healthcare revenue cycle covers everything between a patient's first appointment and the practice's final payment: scheduling and registration, eligibility verification, prior authorization, charge capture, coding, claim submission, payment posting, denial management, and A/R follow-up. HFMA's RCM resource defines it as tracking revenue from the initial encounter through full account resolution.
For infectious disease practices, several stages carry extra weight:
- Hospital follow-up: continuity from inpatient consult to outpatient visit affects coding accuracy and collection speed
- OPAT coordination: authorization for drug and site of care, vascular access, and weekly lab monitoring all touch billing
- Infusion administration: documentation gaps around start/stop times are a common denial trigger
- Buy-and-bill drugs: practices that purchase and bill antimicrobials carry acquisition risk and reporting obligations
Why Revenue Leaks in Infectious Disease Billing
Common leakage points include incomplete infusion documentation, authorization gaps for extended OPAT courses, missed drug-unit charges, and confusion over professional-versus-facility billing when care crosses hospital and outpatient settings.
One concrete example: when a single-dose vial is used and some drug is discarded, CMS's JW/JZ policy requires the JW modifier on a separate claim line reporting the wasted amount, or JZ when nothing is discarded. Get this wrong and claims bounce.
Three RCM Models to Choose From
- Software-focused: you license a platform and your staff runs billing. Works if you have strong in-house billing expertise and want full control.
- Service-focused outsourcing: an external company handles coding, claims, and denials. Fits practices with thin back-office staffing.
- Hybrid: platform plus optional managed services, letting you scale support up or down as volume changes.
Match the model to your claim volume, EHR configuration, and appetite for hands-on denial work.
For practices that want to pressure-test their own numbers before comparing vendors, GrowInfectiousDisease offers free, browser-based tools covering OPAT and infusion economics. The calculators are educational resources and do not replace professional billing or compliance advice.
Top Healthcare Revenue Cycle Management Companies for Infectious Disease Practices in 2026
This is a practical shortlist, not a ranked endorsement. Each company below has documented healthcare RCM capabilities and plausible relevance to infectious disease or ambulatory billing. None has publicly confirmed a dedicated infectious disease product line, so treat specialty fit as a question for your own demo, not an assumption.
| Vendor | Primary Model | Best For |
|---|---|---|
| Optum | Software + managed services + consulting | Health-system affiliated or larger ID groups |
| R1 RCM | End-to-end or modular outsourcing | Larger independent/multisite physician groups |
| NextGen Healthcare | EHR platform + optional managed services | Ambulatory practices wanting integrated clinical + billing |
| athenahealth | Cloud platform + RCM services | Growing multi-location ambulatory groups |
| Greenway Health | Ambulatory billing/coding services + software | Smaller independent practices wanting embedded support |
Optum
Optum operates at health-system scale, combining several distinct offerings rather than one unified product:
- Ambulatory RCM Services: managed revenue-cycle support for physicians, including claims workflows and EHR integration
- Optum Integrity One: a coding, charge-capture, and documentation-integrity platform with AI-assisted code review
- LYNX Outpatient Charge Capture: includes infusion and injection charge calculation, a useful signal for drug-heavy billing
- Medical Coding, A/R Recovery, and Denial Management: available as standalone outsourced functions
Best for: Infectious disease groups affiliated with a hospital or health system, or larger multi-provider practices comfortable navigating a large vendor's account structure.
Why it may fit: LYNX's infusion-application support and Integrity One's charge-capture review suggest genuine experience with complex administration billing, not just generic office-visit coding.
Potential limitations: Optum's materials don't confirm a dedicated OPAT or antimicrobial buy-and-bill program. Smaller independent practices may find contracting and account access slower than with a smaller, more focused partner.
Before signing, ask directly about implementation timelines for your specific EHR, whether you get a dedicated account manager or a shared service pool, who owns unresolved denials after 90 or 180 days, and what data governance looks like for your claim-level reporting.
R1 RCM
R1 positions its physician offering for "independent physician groups, specialties, and existing EHRs," separate from its hospital and health-system business. Comprehensive physician RCM covers the full chain: registration, eligibility, charge capture, coding, claims, payment posting, denials, and patient accounts.
Practices can also choose modular pieces instead of handing over the entire cycle.
Best for: Larger independent infectious disease groups or multisite physician organizations with high claim volume that want one vendor to own the back office end-to-end.
Why it may fit: R1 explicitly serves independent specialty groups and works across existing EHRs rather than forcing a platform switch. R1's Eastside case study describes a multisite physician group reaching a 95% clean claim rate after R1 took over coding, claims, denials, and collections — evidence of physician-billing competence, even if it isn't infectious-disease-specific.
Potential limitations: Dedicated OPAT, infusion administration, or buy-and-bill functionality isn't publicly confirmed for the physician line. Smaller single-physician practices may be a poor volume fit for R1's workforce-driven model.
Questions worth asking: How does transition planning work during the first 90 days? What escalation path exists when a claim stalls? How much workflow customization is realistic versus standardized process?
NextGen Healthcare
NextGen splits its offering by practice size. NextGen Office is built for practices under 10 providers, combining EHR, practice management, and clearinghouse connections with claims scrubbing, denial management, and appeals.
NextGen Enterprise targets mid-size and larger ambulatory groups, running RCM services natively on its Enterprise PM platform with specialty-tailored A/R and denial workflows.
Best for: Independent or multisite ambulatory infectious disease practices that want clinical documentation, charge capture, and billing on one connected platform.
Why it may fit: Both platforms include configurable workflows and specialty clinical templates, plus eligibility verification and pre-submission claim scrubbing — foundational pieces for authorization-heavy ID billing.
Potential limitations: Detailed ID-specific authorization workflows and infusion-specific configuration aren't confirmed in NextGen's public materials. Migrating an existing EHR also means a real implementation and training lift.
Before committing, cover:
- EHR migration timeline and data-conversion process
- Interoperability with hospital systems and reference labs
- Custom report-building for OPAT and infusion volume
- Who owns denial follow-up — your staff, NextGen, or both
- Your ability to export data if you switch vendors later
athenahealth
athenaOne bundles EHR, practice management, and revenue-cycle functions in the cloud, with Revenue Cycle Services available as an add-on for independent practices.
Its Authorization Management service handles payer-requirement checks, clinical-document submission, and outcome tracking for eligible orders after go-live. Current documentation explicitly excludes prescription medications, DME, therapy pre-certifications, lab orders, and retro-authorizations.
Best for: Growing ambulatory infectious disease groups, especially those already comfortable with standardized, cloud-based workflows across multiple locations.
Why it may fit: athenahealth documents electronic eligibility verification, medical coding, and denial resolution as core service functions. In one documented case, a 14-location independent practice added Authorization Management and reported more staff time for patient care and coordination.
Potential limitations: Because prescription medications are excluded from the Authorization Management scope, OPAT and infusion drug authorizations — exactly where ID practices get stuck — may fall outside this particular service. Confirm scope directly with athenahealth.
Ask about whether infusion and specialty-drug authorizations are covered under any current plan, how exceptions get escalated, and what reporting granularity exists by service line.
Greenway Health
Greenway's ambulatory-focused Revenue Services covers billing, claim submission, payment posting, insurance follow-up, denial support, and reporting, aimed explicitly at small practices and ambulatory groups. Greenway Medical Coding adds full-service or targeted complex-case coding from AHIMA/AAPC-certified coders, plus chart-review audits.
Best for: Smaller independent infectious disease practices that want a revenue-cycle partner working alongside existing staff rather than replacing them.
Why it may fit: Greenway's model keeps billing staff embedded with practice staff, preserving visibility into claims and denials. That setup is useful for practices that don't want to lose sight of drug-heavy, high-dollar claims.
Potential limitations: Current materials don't document dedicated OPAT, buy-and-bill, or infusion charge-capture experience. A named case study covers a pediatric practice, not infectious disease, so specialty fit needs direct verification.
Evaluation checklist: Does the implementation team have any documented infusion or specialty-drug billing experience? How is EHR and clearinghouse integration handled? Who's your dedicated financial contact, and what's the escalation process?
How We Chose the Best RCM Companies
We built this shortlist from primary-source documentation (vendor service descriptions, implementation materials, security pages, and named case studies), not rankings or review-site scores.
Specialty and workflow fit. We looked for documented experience with physician groups, ambulatory care, infusion administration, and complex payer workflows. None of the five vendors publicly confirms a dedicated infectious disease product, so this remains a verification step for your evaluation, not a settled fact.
Service model fit. We compared software-only, outsourced, and hybrid models against realistic practice conditions: staffing capacity, desired control, claim volume, and tolerance for standardized processes versus hands-on appeals work.
Technical and operational integration. This covers EHR and practice-management compatibility, clearinghouse connections, authorization workflows, reporting, and data export: all things to confirm in a live demo, not a sales deck.
Financial transparency. Pricing structures are compared only where publicly documented or vendor-confirmed. Ask each vendor to define:
- Key performance indicators and service levels
- Who owns denial follow-up and A/R after a set number of days
- Reporting cadence and format
Security and compliance. We checked for HIPAA commitments, business associate agreement availability, and named certifications like SOC 2 or HITRUST. These disclosures vary by vendor and by product line. A company-wide certification doesn't automatically cover every service you're buying. Confirm scope, not just the badge.
Conclusion
The best RCM partner for your infectious disease practice is the vendor that can handle your OPAT authorizations, infusion charge capture, drug billing, and hospital follow-up claims without you discovering the gaps six months into a contract. Brand size and feature-list length matter less than that operational fit.
Before signing anything, ask for a workflow demonstration using your real scenarios:
- A denied infusion claim
- An expiring OPAT authorization
- A buy-and-bill drug with partial waste
- An aging hospital follow-up balance
How a vendor handles those questions tells you more than any sales deck.
Want to understand your own numbers before you compare vendors? GrowInfectiousDisease offers free, ungated, browser-based tools for examining OPAT economics, infusion revenue, and authorization bottlenecks (no invented rates, no email required). It's a starting point for your own due diligence, not a substitute for vendor evaluation or professional compliance advice.
Frequently Asked Questions
What is a revenue cycle management (RCM) company?
An RCM company helps manage the financial lifecycle from patient access through final payment, covering coding, claims, denials, and collections. Some are software vendors, others are outsourced billing firms, and many offer a hybrid of both.
What is the best revenue cycle management software?
The best option depends on your practice size, EHR, staffing, and specialty workflows. Infectious disease practices should specifically test how a platform handles OPAT, infusion, authorization, and denial management before deciding.
What is outsourcing revenue cycle management?
Outsourcing means handing some or all RCM functions to an external company, which can relieve staffing pressure and add specialized expertise. Review data access, contract terms, and how much visibility you retain into your own claims.
What makes a good revenue cycle manager?
A strong RCM partner understands payer rules, coding and compliance requirements, and denial and A/R recovery. Just as important, they communicate clearly and escalate problems without you having to chase updates.
How should an infectious disease practice choose an RCM company?
Compare specialty experience, OPAT and infusion capabilities, authorization processes, and EHR integration side by side. Then weigh reporting access, account support, pricing structure, and security commitments before signing.
Does an infectious disease practice need a specialty-specific RCM partner?
Not necessarily, but any vendor you choose needs to demonstrate real competence with your services: drug and infusion billing, authorizations, and professional-versus-facility claim coordination. General healthcare experience alone isn't proof of that.
